Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Isoacetoside
2. Isoverbascoside
1. 61303-13-7
2. Isoverbascoside
3. 588ljk42ap
4. [(2r,3r,4s,5r,6r)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
5. Nsc-729649
6. Isoacetoside
7. Unii-588ljk42ap
8. Iso-acteoside
9. Acteoside Isomer
10. Verbascoside,(s)
11. [(2r,3r,4s,5r,6r)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
12. Chembl504873
13. Chebi:192072
14. Dtxsid501317837
15. Hy-n0022
16. Bdbm50386896
17. Mfcd06798947
18. Nsc729649
19. S9128
20. Zinc49898792
21. Akos037514697
22. Ccg-270268
23. Nsc 729649
24. 303i137
25. Q-100709
26. Q27261572
27. ((2r,3r,4s,5r,6r)-6-(3,4-dihydroxyphenethoxy)-3,5-dihydroxy-4-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2-yl)methyl (e)-3-(3,4-dihydroxyphenyl)acrylate
28. (e)-((2r,3r,4s,5r,6r)-6-(3,4-dihydroxyphenethoxy)-3,5-dihydroxy-4-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2-yl)methyl 3-(3,4-dihydroxyphenyl)acrylate
29. .beta.-d-glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-o-(6-deoxy-.alpha.-l-mannopyranosyl)-, 6-((2e)-3-(3,4-dihydroxyphenyl)-2-propenoate)
30. .beta.-d-glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-o-(6-deoxy-.alpha.-l-mannopyranosyl)-6-o-[(2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-
31. 1-o-[2-(3,4-dihydroxyphenyl)ethyl]-3-o-(3alpha,4alpha,5beta-trihydroxy-6alpha-methyltetrahydro-2h-pyran-2beta-yl)-6-o-[3-(3,4-dihydroxyphenyl)acryloyl]-beta-d-glucopyranose
32. 2-(3',4'-dihydroxyphenyl)ethyl 6-o-caffeoyl-3-o-(alpha-l-rhamnopyranosyl)-beta-d-glucopyranoside
33. Beta-d-glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-o-(6-deoxy-alpha-l-mannopyranosyl)-, 6-(3-(3,4-dihydroxyphenyl)-2-propenoate), (e)-
| Molecular Weight | 624.6 g/mol |
|---|---|
| Molecular Formula | C29H36O15 |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 11 |
| Exact Mass | 624.20542044 g/mol |
| Monoisotopic Mass | 624.20542044 g/mol |
| Topological Polar Surface Area | 245 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 936 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Isoacteoside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isoacteoside, including repackagers and relabelers. The FDA regulates Isoacteoside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isoacteoside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Isoacteoside supplier is an individual or a company that provides Isoacteoside active pharmaceutical ingredient (API) or Isoacteoside finished formulations upon request. The Isoacteoside suppliers may include Isoacteoside API manufacturers, exporters, distributors and traders.
Isoacteoside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Isoacteoside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Isoacteoside GMP manufacturer or Isoacteoside GMP API supplier for your needs.
A Isoacteoside CoA (Certificate of Analysis) is a formal document that attests to Isoacteoside's compliance with Isoacteoside specifications and serves as a tool for batch-level quality control.
Isoacteoside CoA mostly includes findings from lab analyses of a specific batch. For each Isoacteoside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Isoacteoside may be tested according to a variety of international standards, such as European Pharmacopoeia (Isoacteoside EP), Isoacteoside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Isoacteoside USP).
LOOKING FOR A SUPPLIER?
